Sign In
Buy ABBV
$217.07
+1.64 (+0.761%)
At Close: Jun 03, 2026
2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
08:15am, Saturday, 14'th Feb 2026
Markets are choppy in 2026, and many investors believe we could see a correction this year. Investors should be prepared with defensive stocks that generate reliable dividends.
Got $500? 2 Pharma Stocks to Buy and Hold Forever.
07:45am, Saturday, 14'th Feb 2026
Stocks in the healthcare sector can often serve as a hedge against broader market volatility. But there are also some high-flying growth stocks, particularly within the pharmaceutical and biotech indu
Abbott Laboratories: A Key Reduction in Robert Bruce's Portfolio
06:01pm, Friday, 13'th Feb 2026
Exploring the Strategic Moves of a Seasoned Value Investor Robert Bruce (Trades, Portfolio) recently submitted the 13F filing for the fourth quarter of 2025, p
AbbVie Inc. (ABBV) Presents at Piper Sandler Virtual Novel Targets in Immunology Symposium Transcript
12:57pm, Friday, 13'th Feb 2026
AbbVie Inc. (ABBV) Presents at Piper Sandler Virtual Novel Targets in Immunology Symposium Transcript
54 Stocks, 9 Megatrends: My Favorite Places To Be While Capital Is 'Forced'
07:30am, Thursday, 12'th Feb 2026
My top-down strategy targets 'mission-critical' sectors where capital is forced by secular and cyclical tailwinds—data centers, energy, AI, defense, and infrastructure. AI-driven data center and ene
1 Reason I'm Never Selling AbbVie Stock
04:44am, Thursday, 12'th Feb 2026
AbbVie has proven its ability to adapt to changes and challenges and continue to thrive. This ability to evolve is arguably the most important trait for a company to possess.
AbbVie sues US health agency over Botox price controls
06:49pm, Wednesday, 11'th Feb 2026
AbbVie sued the U.S. Department of Health and Human Services on Wednesday, challenging a decision by the Centers for Medicare & Medicaid Services to impose price controls for Botox.
Abbvie sues US health agency over Botox
05:13pm, Wednesday, 11'th Feb 2026
Abbvie sued the U.S. Department of Health and Human Services on Wednesday, challenging a decision by the Centers for Medicare & Medicaid Services to select Botox for prescription drug price controls e
2 Urgent Sells And 2 No Brainer Dividend Buys
04:06pm, Wednesday, 11'th Feb 2026
One thing I've learned is the pendulum always swings. It is in our best approach to sell high and buy low. This has worked well for us, as our returns suggest.
Here's Why AbbVie (ABBV) is a Strong Value Stock
10:40am, Tuesday, 10'th Feb 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
10:00am, Tuesday, 10'th Feb 2026
Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.
Dividend Kings: No Ideal Buys In February's 57
09:45am, Tuesday, 10'th Feb 2026
Dividend Kings remain broadly overvalued, with only a handful approaching fair price despite elevated yields. Three Dividend Kings—Canadian Utilities, Fortis, and Hormel—currently meet the dogcatc
Here's What Will Drive AbbVie's Top-line Growth in 2026
09:35am, Tuesday, 10'th Feb 2026
ABBV sees 2026 revenues rising to $67B as Rinvoq and Skyrizi drive growth, with neuroscience gains offsetting Humira erosion and oncology headwinds.
AbbVie Inc. $ABBV Shares Sold by Profund Advisors LLC
05:05am, Monday, 09'th Feb 2026
Profund Advisors LLC reduced its stake in shares of AbbVie Inc. (NYSE: ABBV) by 9.4% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The
Legacy Financial Strategies LLC Sells 12,664 Shares of AbbVie Inc. $ABBV
05:05am, Monday, 09'th Feb 2026
Legacy Financial Strategies LLC lessened its position in AbbVie Inc. (NYSE: ABBV) by 66.6% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission
